MedPath

广东科泓药业有限公司

Ownership
-
Established
1991-05-06
Employees
-
Market Cap
-
Website
http://www.kelun.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

53

NMPA:53

Drug Approvals

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20254328
Approval Date
May 27, 2025
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20254329
Approval Date
May 27, 2025
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20258076
Approval Date
May 9, 2025
NMPA

Calcium Gluconate and Sodium Chloride Injection

Product Name
葡萄糖酸钙氯化钠注射液
Approval Number
国药准字H20254016
Approval Date
Apr 30, 2025
NMPA

Calcium Gluconate and Sodium Chloride Injection

Product Name
葡萄糖酸钙氯化钠注射液
Approval Number
国药准字H20254015
Approval Date
Apr 30, 2025
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20258026
Approval Date
Mar 10, 2025
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20253561
Approval Date
Mar 4, 2025
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20253560
Approval Date
Mar 4, 2025
NMPA

Multiple Electrolytes Injection(Ⅱ)

Product Name
复方电解质注射液(Ⅱ)
Approval Number
国药准字H20244002
Approval Date
Jun 11, 2024
NMPA

Multiple Electrolytes Injection(Ⅱ)

Product Name
复方电解质注射液(Ⅱ)
Approval Number
国药准字H20244003
Approval Date
Jun 11, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.